GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » Change In Receivables

Brasil Pharma (BSP:BPHA3) Change In Receivables : R$8.60 Mil (TTM As of Mar. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma Change In Receivables?

Brasil Pharma's change in receivables for the quarter that ended in Mar. 2019 was R$0.30 Mil. It means Brasil Pharma's Accounts Receivable declined by R$0.30 Mil from Dec. 2018 to Mar. 2019 .

Brasil Pharma's change in receivables for the fiscal year that ended in Dec. 2018 was R$3.00 Mil. It means Brasil Pharma's Accounts Receivable declined by R$3.00 Mil from Dec. 2017 to Dec. 2018 .

Brasil Pharma's Accounts Receivable for the quarter that ended in Mar. 2019 was R$1.74 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Brasil Pharma's Days Sales Outstanding for the three months ended in Mar. 2019 was 96.69.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Brasil Pharma's liquidation value for the three months ended in Mar. 2019 was R$-360.67 Mil.


Brasil Pharma Change In Receivables Historical Data

The historical data trend for Brasil Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma Change In Receivables Chart

Brasil Pharma Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Change In Receivables
Get a 7-Day Free Trial Premium Member Only 106.52 -37.02 94.30 34.95 3.00

Brasil Pharma Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.30 8.19 3.47 -3.35 0.30

Brasil Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was R$8.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brasil Pharma  (BSP:BPHA3) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Brasil Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2019 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.742/1.644*91
=96.69

2. In Ben Graham's calculation of liquidation value, Brasil Pharma's accounts receivable are only considered to be worth 75% of book value:

Brasil Pharma's liquidation value for the quarter that ended in Mar. 2019 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.809-362.784+0.75 * 1.742+0.5 * 0
=-360.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brasil Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Brasil Pharma Business Description

Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900
Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma Headlines

No Headlines